Aliaksandr Bulhak

PPAR-α activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway

Aliaksandr Bulhak, Christian Jung, Claes‐Göran Östenson et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2009 · 117 citations

Nitric Oxide, Cardiovascular Pharmacology, Cardiovascular Function +22

Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide

Adrian Gonon, Ulrika Widegren, Aliaksandr Bulhak et al. · Cardiovascular Research · 2008 · 80 citations · Full text

Protection against myocardial ischaemia/reperfusion injury by PPAR–α activation is related to production of nitric oxide and endothelin–1

Aliaksandr Bulhak, P.‐O. Sjöquist, Cang‐Bao Xu et al. · Basic Research in Cardiology · 2006 · 60 citations

Inflammation, Ppar–α Activation, Molecular Physiology +11

Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation

Aliaksandr Bulhak, Joy Roy, Ulf Hedin et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2007 · 46 citations

Lipid Peroxidation, Cardiovascular Pharmacology, Cardiovascular Toxicity +20

Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia–reperfusion in vivo

Andrey Gourine, Aliaksandr Bulhak, Adrian Gonon et al. · Nitric Oxide · 2002 · 35 citations

Cardioprotective Effect, Cardiogenic Shock, Brief Exposure +10